B. Holskin

发表

Comparison of two homogeneous cell-based kinase assays for JAK2 V617F: SureFire pSTAT5 and GeneBLAzer fluorescence resonance energy transfer assays.

Jennifer L. Mason, J. Qian, T. Angeles, 2012, Assay and drug development technologies.

Anaplastic lymphoma kinase activity is essential for the proliferation and survival of anaplastic large-cell lymphoma cells.

B. Ruggeri, T. Underiner, B. Dorsey, 2006, Blood.

Inhibition of mixed lineage kinase 3 attenuates MPP+-induced neurotoxicity in SH-SY5Y cells

D. Bozyczko‐Coyne, A. Maroney, G. Ghadge, 2004, Brain Research.

Induction of sensitivity to the cytotoxic action of tumor necrosis factor alpha by adenovirus E1A is independent of transformation and transcriptional activation

R. Ames, D. Shalloway, Mann-Jy Chen, 1990, Journal of virology.

A continuous fluorescence-based assay of human cytomegalovirus protease using a peptide substrate.

B. Dunn, M. Bukhtiyarova, J. D. de CHASTONAY, 1995, Analytical biochemistry.

Purification and characterization of human recombinant interleukin-1 beta.

P. Young, P. Simon, K. Johanson, 1987, The Journal of biological chemistry.

Preliminary X-ray crystallography studies of recombinant human interleukin-1 alpha. Purification and structural characterization.

S. Carr, M. Lewis, P. Young, 1989, The Journal of biological chemistry.

Induction by E1A oncogene expression of cellular susceptibility to lysis by TNF

D. Shalloway, J. Strickler, M. A. Clark, 1987, Nature.

Improvement of inhibitor identification for heat shock protein 90α by utilizing a red-shifted fluorescence polarization probe.

T. Underiner, J. Qian, T. Angeles, 2012, Assay and drug development technologies.

E. coli expression of highly active recombinant murine interleukin-10

C. Nathan, C. Bogdan, B. Holskin, 1993 .

Role of tumor necrosis factor-alpha in E1A oncogene-induced susceptibility of neoplastic cells to lysis by natural killer cells and activated macrophages.

B. Wilson, D. Shalloway, M. Chen, 1989, Journal of immunology.

ALK mutants in the kinase domain exhibit altered kinase activity and differential sensitivity to small molecule ALK inhibitors.

A. Ghose, B. Ruggeri, J. T. Durkin, 2009, Biochemistry.

Mixed-lineage kinase 1 and mixed-lineage kinase 3 subtype-selective dihydronaphthyl[3,4-a]pyrrolo[3,4-c]carbazole-5-ones: optimization, mixed-lineage kinase 1 crystallography, and oral in vivo activity in 1-methyl-4-phenyltetrahydropyridine models.

D. Bozyczko‐Coyne, A. Fedorov, E. Fedorov, 2008, Journal of Medicinal Chemistry.

Phosphoregulation of mixed-lineage kinase 1 activity by multiple phosphorylation in the activation loop.

Karla K Kopec, C. Spais, J. T. Durkin, 2004, Biochemistry.

Discovery of 7-arylsulfonyl-1,2,3,4, 4a,9a-hexahydro-benzo[4,5]furo[2,3-c]pyridines: identification of a potent and selective 5-HT₆ receptor antagonist showing activity in rat social recognition test.

Karla K Kopec, E. Duzic, E. Bacon, 2012, Bioorganic & medicinal chemistry letters.

Novel brain penetrant benzofuropiperidine 5-HT₆ receptor antagonists.

Karla K Kopec, E. Duzic, E. Bacon, 2012, Bioorganic & medicinal chemistry letters.

Aequorin functional assay for characterization of G-protein-coupled receptors: implementation with cryopreserved transiently transfected cells.

E. Duzic, V. Dupriez, M. Ator, 2010, Analytical biochemistry.

Modification of CellSensor irf1-bla TF-1 and irf1-bla HEL assays for direct comparison of wild-type JAK2 and JAK2 V617F inhibition.

Jennifer L. Mason, K. Wells-Knecht, T. Angeles, 2011, Assay and drug development technologies.